• Both the vaccines generated a robust immune response in the children, the FDA said
The US Food and Drug Administration’s committee of independent vaccine experts on Wednesday voted to recommend authorization of Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) Covid-19 vaccine for kids as young as six months.
The expert committee voted 21 to 0 in favour of making the vaccine available for children in the age group of 6 months to under 5 years.
According to the FDA, both the vaccines generated a robust immune response in the children, similar to those in young adults and were generally safe and effective.
After the committee’s recommendation, the FDA is expected to authorize the vaccine this week. Before the shots could be made available in the market for the kids, the vaccine will also need authorization from the Centers for Disease Control and Prevention.
Picture Credits: WSJ
ALSO READ: